Jennifer Jarrett, Chief Operating Officer at Arcus Biosciences, Inc. (RCUS), sold 100,582 shares at $18.97 ($1.9M) on 2025-11-07, disclosed to the SEC on 2025-11-12.
Scheduled sale ($1.9M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.97 | 50,291 | $954K | 50.0% |
| 2 | $18.97 | 50,291 | $954K | 50.0% |
| Total | $18.97 avg | 100,582 | $1.9M | 100% |
| Filing → |
| RCUS | SELL | 2024-03-29 | $405K | — | Filing → |
| RCUS | SELL | 2024-03-20 | $458K | — | Filing → |
| RCUS | SELL | 2024-02-28 | $2.4M | — | Filing → |